



Q+A: After all the hype, green investing is 'growing up, not winding down'
After years of hype, ethical and green investing has cooled. But instead of going away, it's evolving. Sean Aylmer speaks with Dugald Higgins, Head of Responsible Investment and Real Assets at Zenith Investment Partners, about where sustainable investing now sits, why Australia has held steady whi…

Q+A: Did the RBA have no choice but to hike?
The Reserve Bank has lifted interest rates for the first time in two years, and while the hike was widely expected by markets, not all economists thought the RBA would do it. AMP Deputy Chief Economist Diana Mousina explains why the unanimous vote raised eyebrows, and why she believes this may sti…

Q+A: The bull and bear cases for equities in 2026
Roger Montgomery, founder and Chief Investment Officer at Montgomery Investment Management, looks back at the forces that drove markets in 2025 — from the AI boom to the “great broadening” beyond US megacaps. He talks to Sean Aylmer about the bull and bear cases for US equities in 2026, why the US…

Q+A: The Week Ahead | 2 Feb 2026
It's all about the RBA this week, with interest rates tipped to rise. Michael Thompson is joined by economist Stephen Koukoulas to look at what to expect. Fear & Greed Q+A: Join Sean Aylmer & Michael Thompson and the team as they answer questions on business, investing, economics, politics and mor…

Q+A: Behind the scenes at the Olympics
This week the Winter Olympics kick off in Italy. Sean Aylmer and Michael Thompson talk about the big sporting events they've covered in the media, from the Atlanta and London Olympics, to the US Open tennis. Fear & Greed Q+A: Join Sean Aylmer, Michael Thompson and Adam Lang as they answer question…

Q+A: The GLP-1 drugs changing health and markets
Weight-loss drugs like Ozempic and Wegovy are reshaping healthcare — and potentially the economy. Dr Zac Turner explains to Sean Aylmer how GLP-1 drugs work, what we’re still learning about their long-term effects, why the next generation matters, and how these medications may go far beyond weight…

Q+A: This economist is calling for a 0.4pc rate hike next week
A rate hike is now firmly back on the table next week after a sharp jump in inflation. Economist Warren Hogan, from EQ Economics and Judo Bank, talks to Sean Aylmer about where the RBA went wrong, why inflation is proving stubborn, and why the Reserve Bank should increase rates by 40 basis points…

Q+A: Could this be the answer to Australia's rental crisis?
With house prices rising and the rental crisis deepening, build-to-rent is emerging as a serious alternative to Australia’s traditional rental model. Local: Residential founder and co-CEO Matt Berg talks to Sean Aylmer about how institutionally owned housing works, why long-term leases matter, and…

Q+A: The high stakes behind Rio Tinto & Glencore mega merger talks
Australia’s miners are entering a new phase of consolidation, with a potential mega merger between Rio Tinto and Glencore putting copper, scale and growth firmly in focus. Sean Aylmer speaks to Brian Szeto from Morningstar DBRS in Canada about why the biggest miners are doing deals now, why copper…

Q+A: The Week Ahead | 26 Jan 2026
It's a very big week for the economy: the December quarter inflation data is out on Wednesday, and Michael Thompson is joined by economist Stephen Koukoulas to look at what to expect, and what the number will need to be in order to avoid an interest rate hike when the RBA board meets next week. Fe…